Navigation Links
NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference
Date:3/14/2008

SAN DIEGO, March 14 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Kevin O'Boyle, Executive Vice President and Chief Financial Officer, is scheduled to present at the Lehman Brothers Eleventh Annual Global Healthcare Conference at the Loews Miami Beach Hotel in Miami Beach, FL on Wednesday, March 19, 2008 at 10:15 a.m. ET.

A live Web cast of the presentation will be available online from the investor relations page of the Company's corporate Web site at http://www.nuvasive.com. After the live Web cast, the presentation will remain available on NuVasive's Web site, http://www.nuvasive.com, for 30 days.

About NuVasive

NuVasive is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $4.2 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS(TM), as well as a growing offering of cervical and motion preservation products.

The MAS platform offers advantages for both patients and surgeons such as reduced surgery and hospitalization time and faster recovery. MAS combines three categories of current product offerings: NeuroVision(R) a proprietary software-driven nerve avoidance system; MaXcess(R) a unique split-blade design retraction system; and specialized implants, like SpheRx(R) and CoRoent(R), that collectively minimize soft tissue disruption during spine surgery while allowing maximum visualization and surgical reproducibility. NuVasive's product offering is also focused on cervical internal fixation products and its R&D pipe
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
2. NuVasive to Host Investor Reception on September 11, 2007
3. NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results
4. NuVasive to Present at Canaccord Adams Small-Cap Orthopedics Conference
5. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
6. Avicena Group to Present at Noble Financial Conference
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CEL-SCI to Present at the Noble Financial Conference
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , ... July 07, 2015 , ... CSM, a leading ... as Vice President of Finance. Morse has an extensive background in financial management and ... the CSM team. In his new role, Morse will oversee all financial areas of ...
(Date:7/6/2015)... ... 06, 2015 , ... A study by a multidisciplinary research ... fungi adapt through genetic modifications to fight back against the effects of medication ... These insights may provide clues to new ways to treat notoriously difficult-to-cure fungal ...
(Date:7/6/2015)... ... 2015 , ... Discovery of new biomarkers for patient screening ... the global molecular diagnostics market. BCC Research reveals in its new report that ... tests will increase demand for inexpensive and accurate tests for genetic compatibility for ...
(Date:7/6/2015)... , July 6, 2015 ImmunoCellular Therapeutics, Ltd. ... an agreement with Novella Clinical (Novella), to ... patients with newly diagnosed glioblastoma. Novella is a full-service, ... to small to mid-sized oncology companies. The ICT-107 phase ... the US, Europe and ...
Breaking Biology Technology:CSM Appoints Michael Morse as Vice President of Finance 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 3Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 4Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 2Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 3ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2
... Pioneer in High Throughput SNP Discovery Brings ... Oct. 14 BioNanomatrix, Inc., a developer,of ... and biomedical research, today announced the appointment ... Ph.D., to its Scientific,Advisory Board (SAB). Dr. ...
... offers unique opportunities to advance the life sciences ... biological materials with unprecedented resolution. The ability to ... of genomics, proteomics and cell adhesion, and may ... screening and disease detection, even when sample volumes ...
... of Late Stent Thrombosis Reported in CUSTOM I, II, and III ... ... PARK, Calif., Oct. 13 ,XTENT, Inc. (Nasdaq: XTNT ) today announced ... that reinforces the,efficacy of the Custom NX(R) drug eluting stent (DES) system ...
Cached Biology Technology:BioNanomatrix Announces Appointment of Dr. Pui-Yan Kwok to Its Scientific Advisory Board 2Researchers write protein nanoarrays using a fountain pen and electric fields 2Researchers write protein nanoarrays using a fountain pen and electric fields 3Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years 2Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years 3
(Date:6/17/2015)... , June 17, 2015  Crossmatch™, a leading ... that its U.are.U ® 4500 fingerprint readers ... Eateries, Inc., a San Jose, ... to increase security, improve accountability and reduce fraud ... instant, non-repudiable identity confirmation for employee sign in ...
(Date:6/16/2015)... Fingerprint Cards has received an order ... company,s portfolio from one of its module partners in ... place during the third quarter 2015. The sensors will be ... Jörgen Lantto, CEO of FPC, comments: " This ... interest from smartphone OEMs in integrating touch fingerprint sensors in ...
(Date:6/15/2015)... A new report [ 1 ] ... consumers using mobile banking applications want their mobile devices to ... instead of having to prove who they are with passwords ...   -   The Fusion of Financial Services, Mobile and ... channel used by Gen X and Gen Y to access ...
Breaking Biology News(10 mins):Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4
... Tide" event that occurred off the coast of El ... some 200 sea turtles, according to test results released ... organizations. , Responding to requests from the Salvadoran government ... WCS veterinary pathologist Dr. Julie White journeyed to the ...
... McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins have ... what many have termed "junk" DNA and identified regions ... that these control regions from different species don't have ... will be published online at Science Express March 23. ...
... at the McKusick-Nathans Institute of Genetic Medicine at Johns ... of analyzing what many have termed "junk" DNA and ... have found that these control regions from different species ... The study will be published online at Science Express ...
Cached Biology News:Red Tide causes sea turtle die-off in El Salvador 2Infused spleen cells found not to impact islet recovery and reversal of type 1 diabetes in mice 2Infused spleen cells found not to impact islet recovery and reversal of type 1 diabetes in mice 3Junk DNA may not be so junky after all 2Junk DNA may not be so junky after all 3
... Cell Identification Kit. ALDEFLUORs ... substrate for the enzyme ... is highly expressed in ... making ALDH an extremely ...
... System is the cost-effective solution for entry ... to common research imaging tasks, MetaVue enables ... simple image analysis. Compatibility with MetaMorphs ... that MetaVue has the power to drive ...
Sterile, Cell culture tested...
... many modifications to the original formulas in efforts ... play an important role in tissue,culture. A salt ... osmotic balance in the medium and to provide ... is as valuable today as when it was ...
Biology Products: